Growth Metrics

Inogen (INGN) Free Cash Flow Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -1.82%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 226.77%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.73%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -51.69%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -109.40%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 133.09%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 363.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 108.16%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 29.12%
10 Inogen 165.85 Mn 71.44 Mn 37.86 Mn 59.64%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 59.64%
Dec 31, 2025 81.03%
Sep 30, 2025 -57.97%
Jun 30, 2025 -53.11%
Mar 31, 2025 -181.93%
Dec 31, 2024 -1,438.14%
Sep 30, 2024 566.60%
Jun 30, 2024 96.43%
Mar 31, 2024 4.82%
Dec 31, 2023 102.55%
Sep 30, 2023 79.84%
Jun 30, 2023 17.54%
Mar 31, 2023 65.00%
Dec 31, 2022 -417.79%
Sep 30, 2022 -79.72%
Jun 30, 2022 -75.38%
Mar 31, 2022 -753.58%
Dec 31, 2021 -61.60%
Sep 30, 2021 -218.88%
Jun 30, 2021 -7.47%
Mar 31, 2021 396.38%
Dec 31, 2020 142.10%
Sep 30, 2020 -78.62%
Jun 30, 2020 -14.52%
Mar 31, 2020 65.94%
Dec 31, 2019 40.61%
Sep 30, 2019 -11.73%
Jun 30, 2019 -6.30%
Mar 31, 2019 -127.12%
Dec 31, 2018 -70.34%
Sep 30, 2018 21.44%
Jun 30, 2018 7.02%
Mar 31, 2018 -19.45%
Dec 31, 2017 203.64%
Sep 30, 2017 75.55%
Jun 30, 2017 50.67%
Mar 31, 2017 210.58%
Dec 31, 2016 -75.42%
Sep 30, 2016 -10.53%
Jun 30, 2016 2,287.55%
Mar 31, 2016 -26.25%
Dec 31, 2015 424.47%
Sep 30, 2015 257.43%
Jun 30, 2015 -94.68%
Mar 31, 2015 467.51%
Dec 31, 2014 150.69%
Sep 30, 2014 -71.86%
Jun 30, 2014 2,364.00%
Mar 31, 2014 -219.62%